Skip to main content
Livermore
Livermore
ZHEN

Gryphon Financial Partners LLC

SEC CIK
0001729094
Latest filing
Aug 5, 2026

EW holding history

Edwards Lifesciences Corp in every 13F filed by Gryphon Financial Partners LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

EW overviewAll 13F holders of EWFull Q2 2026 holdings

Shares (Q2 2026)
3,566
Value
$322.6K
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of EW by Gryphon Financial Partners LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,566$322.6K<0.1%+589+19.8%AddedHolders
Q1 20262,977$238.4K<0.1%−67−2.2%ReducedHolders
Q4 20253,044$259.5K<0.1%−38−1.2%ReducedHolders
Q3 20253,082$239.7K<0.1%+336+12.2%AddedHolders
Q2 20252,746$214.8K<0.1%+2,746NewHolders
Q1 20250$00.0%−2,946−100.0%Sold outHolders
Q4 20242,946$218.1K<0.1%−1,374−31.8%ReducedHolders
Q3 20244,320$285.1K<0.1%−365−7.8%ReducedHolders
Q2 20244,685$432.8K0.1%−457−8.9%ReducedHolders
Q1 20245,142$491.4K0.1%−1,312−20.3%ReducedHolders
Q4 20236,454$680.7K0.1%+1,698+35.7%AddedHolders
Q3 20234,756$329.5K0.1%−182−3.7%ReducedHolders
Q2 20234,938$465.8K0.1%−20.0%ReducedHolders
Q1 20234,940$408.7K0.1%+5+0.1%AddedHolders
Q4 20224,935$368.2K0.1%+157+3.3%AddedHolders
Q3 20224,778$395.0K0.1%−165−3.3%ReducedHolders
Q2 20224,943$470.0K0.1%+365+8.0%AddedHolders
Q1 20224,578$538.0K0.1%−698−13.2%ReducedHolders
Q4 20215,276$684.0K0.1%−409−7.2%ReducedHolders
Q3 20215,685$643.0K0.1%−571−9.1%ReducedHolders
Q2 20216,256$520.0K0.1%+126+2.1%AddedHolders
Q1 20216,130$512.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.